Welcome Cure Secures $500K in Pre-Series A Funding Round
- ByStartupStory | October 19, 2023
Welcome Cure has secured over 4 crore in a pre-series A round, with Inflection Point Ventures (IPV) leading the investment. The Mumbai-based startup aims to raise more than 16 crore in the current funding round. These funds will be channeled towards various growth initiatives, encompassing talent acquisition, technology enhancements, and marketing efforts, as stated by Welcome Cure in a press release.
Founded by Jawahar Shah, Punit Desai, and Nidhi Shah, Welcome Cure operates as a fully integrated homeopathy technology company, offering AI-powered solutions for doctors and patients. Their approach ensures effective prescriptions and convenient access to healthcare, regardless of location.
The startup reports having 2.5 million platform users and over 1.5 million registered patients in more than 36 countries. Additionally, their software business caters to over 1 lakh doctors across 140 countries.
Exciting news! We’re now on WhatsApp Channels too. Subscribe today by clicking the link and stay updated with the latest insights in the startup ecosystem! Click here!
IPV has an impressive track record, having invested over Rs 600 crore in more than 190 deals. In 2023, the venture firm supported several companies, including Answer Genomics, Oorjaa, 13SQFT.com, Beyobo, Dusminute, and InsideFPV, among others.
Follow Startup Story
Related Posts
